​

GeneDx Ownership | Who Owns GeneDx?

OverviewForecastRevenueFinancialsChartTranscripts

GeneDx Ownership Summary

GeneDx is owned by 100.96% institutional investors, 12.27% insiders. Casdin capital is the largest institutional shareholder, holding 12.94% of WGS shares.

WGS Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockGeneDx100.96%12.27%-13.23%
SectorHealthcare Stocks 279.15%10.63%-189.78%
IndustryHealthcare Information Services Stocks 36.04%11.09%52.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Casdin capital3.51M12.94%$269.56M
Corvex management lp2.47M9.13%$190.13M
Blackrock funding, inc. /de1.18M4.35%$90.68M
Goldman sachs group1.14M4.22%$87.89M
Oracle investment management1.02M3.78%$78.66M
Vanguard group1.01M3.71%$77.34M
William blair investment management670.00K2.47%$51.50M
Lord, abbett630.47K2.33%$48.46M
Fred alger management546.05K2.02%$41.97M
Fmr402.49K1.49%$30.94M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Oracle investment management1.02M42.83%$78.66M
Casdin capital3.51M17.94%$269.56M
Gagnon advisors187.62K9.23%$14.42M
Gagnon securities359.38K5.57%$27.62M
Corvex management lp2.47M5.28%$190.13M
Options solutions117.27K3.92%$9.01M
Divisadero street capital management, lp288.24K2.59%$22.15M
Tri locum partners lp127.57K2.03%$9.80M
Next century growth investors312.01K1.80%$23.98M
Zweig-dimenna associates309.50K1.78%$23.79M

Top Buyers

HolderShares% AssetsChange
William blair investment management670.00K0.13%670.00K
Lord, abbett630.47K0.15%630.47K
Macquarie group384.48K0.04%384.48K
Fmr402.49K0.00%348.67K
Zweig-dimenna associates309.50K1.78%309.50K

Top Sellers

HolderShares% AssetsChange
Millennium management58.80K0.00%-515.63K
Blackstone---420.71K
Point72 asset management63.09K0.01%-230.58K
Gagnon securities359.38K5.57%-182.57K
Deutsche bank ag\10.38K0.00%-113.73K

New Positions

HolderShares% AssetsChangeValue
William blair investment management670.00K0.13%670.00K$51.50M
Lord, abbett630.47K0.15%630.47K$48.46M
Macquarie group384.48K0.04%384.48K$29.55M
Zweig-dimenna associates309.50K1.78%309.50K$23.79M
Raymond james financial265.05K0.01%265.05K$20.37M

Sold Out

HolderChange
Allworth financial lp-2.00
Mather group, llc.-2.00
Parallel advisors-3.00
Org partners-5.00
Stephens consulting-5.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202524215.24%28,417,95020.78%1001.34%144-4.64%6272.22%
Dec 31, 202419836.55%21,822,46915.86%801.67%14145.36%3332.00%
Sep 30, 202414557.61%18,835,00115.66%691.86%9746.97%25127.27%
Jun 30, 20249250.82%16,284,87717.09%612.15%6688.57%1137.50%
Mar 31, 20246122.00%13,908,27011.80%532.33%3594.44%8-50.00%

Recent Insider Transactions

DateNameRoleActivityValue
Jul 09, 2025Feeley Kevin CHIEF FINANCIAL OFFICERSell$490.85K
Jul 09, 2025Stueland Katherine Chief Executive OfficerSell$299.46K
Jul 01, 2025Stueland Katherine Chief Executive OfficerSell$12.48K
Jul 01, 2025Stueland Katherine Chief Executive OfficerSell$628.22K
Jul 01, 2025Stueland Katherine Chief Executive OfficerSell$237.48K

Insider Transactions Trends

DateBuySell
2025 Q3-7
2025 Q2537
2025 Q1-30
2024 Q4-38
2024 Q3-26

WGS Ownership FAQ

Who Owns GeneDx?

GeneDx shareholders are primarily institutional investors at 100.96%, followed by 12.27% insiders and -13.23% retail investors. The average institutional ownership in GeneDx's industry, Healthcare Information Services Stocks , is 36.04%, which GeneDx exceeds.

Who owns the most shares of GeneDx?

GeneDx’s largest shareholders are Casdin capital (3.51M shares, 12.94%), Corvex management lp (2.47M shares, 9.13%), and Blackrock funding, inc. /de (1.18M shares, 4.35%). Together, they hold 26.43% of GeneDx’s total shares outstanding.

Does Blackrock own GeneDx?

BlackRock is not among the top 10 institutional shareholders of GeneDx.

Who is GeneDx’s biggest shareholder by percentage of total assets invested?

Oracle investment management is GeneDx’s biggest shareholder by percentage of total assets invested, with 42.83% of its assets in 1.02M GeneDx shares, valued at 78.66M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools